BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6431061)

  • 1. Stoichiometric Tc-99m RBC labeling using stable kit solutions of stannous chloride and EDTA: concise communication.
    Mock BH; Wellman HN
    J Nucl Med; 1984 Aug; 25(8):881-6. PubMed ID: 6431061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultratag RBC kit for combined cardiac first-pass and multigated acquisition studies.
    Stallings LE; Cheng KT; Spicer KM; Wiegner R; Humphries JK
    J Nucl Med Technol; 1997 Mar; 25(1):44-8. PubMed ID: 9239603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium-99m labeling of red blood cells: in vitro evaluation of a new approach.
    Kelbaek H
    J Nucl Med; 1986 Nov; 27(11):1770-3. PubMed ID: 3772511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technical problems associated with the production of technetium Tc 99m tin(II) pyrophosphate kits.
    Kowalsky RJ; Dalton DR
    Am J Hosp Pharm; 1981 Nov; 38(11):1722-6. PubMed ID: 7304626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of in vitro RBC labeling with the UltraTag RBC kit versus in vivo labeling.
    Patrick ST; Glowniak JV; Turner FE; Robbins MS; Wolfangel RG
    J Nucl Med; 1991 Feb; 32(2):242-4. PubMed ID: 1992026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of selected antineoplastic agents on the labeling of erythrocytes with technetium-99m using the UltraTag RBC kit.
    Spicer JA; Hladik WB; Mulberry WE
    J Nucl Med Technol; 1999 Jun; 27(2):132-5. PubMed ID: 10353111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Sn(II) ion concentration and heparin on technetium-99m red blood cell labeling.
    Rao SA; Knobel J; Collier BD; Isitman AT
    J Nucl Med; 1986 Jul; 27(7):1202-6. PubMed ID: 3014088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte labeling with technetium-99m tin colloids.
    Mock BH; English D
    J Nucl Med; 1987 Sep; 28(9):1471-7. PubMed ID: 3625299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m radiopharmaceutical preparation by surface adsorbed stannous ions.
    Salehi N; Lichtenstein M; Pojer PM
    J Nucl Med; 1987 Jun; 28(6):1041-6. PubMed ID: 3675734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo labeling of red blood cells with Tc-99m with stannous pyridoxylideneaminates.
    Kato M
    J Nucl Med; 1979 Oct; 20(10):1071-4. PubMed ID: 536758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative evaluation of techniques for rapid and efficient in vivo labeling of red cells with [99mTc] pertechnetate.
    Hamilton RG; Alderson PO
    J Nucl Med; 1977 Oct; 18(10):1010-3. PubMed ID: 903468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labeling of red blood cells with Tc-99m after oral administration of SnCl2: concise communication.
    Patel MC; Parab PB; Samuel AM; Ganatra RD
    J Nucl Med; 1979 Aug; 20(8):877-81. PubMed ID: 541736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kit formulation for 99mTc-labeling of recombinant anti-HER2 Affibody molecules with a C-terminally engineered cysteine.
    Ahlgren S; Andersson K; Tolmachev V
    Nucl Med Biol; 2010 Jul; 37(5):539-46. PubMed ID: 20610158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m labeling by means of stannous pyrophosphate: application to bleomycin and red blood cells.
    Bardy A; Douyé H; Gobin R; Beydon J; de Tovar G; Pannecière C; Hégésippe M
    J Nucl Med; 1975 May; 16(5):435-7. PubMed ID: 53279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technical parameters of in vivo red blood cell labeling with Technetium-99m.
    Zimmer AM; Pavel DG; Karesh SM
    Nuklearmedizin; 1979 Dec; 18(5):241-5. PubMed ID: 547251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tc-99m-labeled red blood cells for the measurement of red cell mass in newborn infants: concise communication.
    Linderkamp O; Betke K; Fendel H; Klemm J; Lorenzen K; Riegel KP
    J Nucl Med; 1980 Jul; 21(7):637-40. PubMed ID: 7391836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of labeling procedures and in vivo stability of 99mTc-red blood cells.
    Ryo UY; Mohammadzadeh AA; Siddiqui A; Colombetti LG; Pinsky SM
    J Nucl Med; 1976 Feb; 17(02):133-6. PubMed ID: 1245875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified method for the in vivo labeling of red blood cells with Tc-99m: concise communication.
    Callahan RJ; Froelich JW; McKusick KA; Leppo J; Strauss HW
    J Nucl Med; 1982 Apr; 23(4):315-8. PubMed ID: 6279801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro technetium-99m red blood cell labeling using commercial stannous pyrophosphate.
    Zimmer AM
    Am J Hosp Pharm; 1977 Mar; 34(3):264-7. PubMed ID: 857670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo distribution of Tc-99m(Sn)pyridoxylideneisoleucine: effects of storage and labeling conditions. Concise communication.
    Kato M
    J Nucl Med; 1979 Nov; 20(11):1189-93. PubMed ID: 536780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.